280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Election of Directors at Alumis Inc. Annual Meeting - James Tananbaum Elected
Investor Presentation
Annual Report to Security Holders
Reports First Quarter 2026 Financial Results and Highlights Recent Achievements
Reports Year End 2025 Financial Results and Highlights
Alumis Inc. Reports Preliminary Cash of $308.6 Million as of December 31, 2025
Envudeucitinib Delivers Leading Skin Clearance Among Next-Generation Oral Plaque Psoriasis Therapies in Phase 3 Program
Q1
FY 2025
Q3
Q2
Amended Annual Report
FY 2024
S-3ASR
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus Filed Pursuant to Rule 425
Definitive Proxy Statement
Additional Proxy Materials
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report